Dr. Bateman answers IOM questions from the community: Part 1
Clark Ellis brings us Part 1 of an interview with Dr. Lucinda Bateman, where she answered questions posed by the patient community ...
Discuss the article on the Forums.

Tarvacin "Anti-PS" antiviral immunotherapy

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by acer2000, Nov 18, 2009.

  1. acer2000

    acer2000 Senior Member

    Messages:
    670
    Likes:
    461
    I found this information when surfing HIV forums lookin for info on new anti-retroviral therapies (with a focus on eradication):

    This compound is called "Bavituximab" or "Tarvacin" - at least I think they are the same. Made by a company called Peregrine Pharmaceuticals. About halfway through this article on the NIH site it lists most of the pathogens this is effective against.

    http://www3.niaid.nih.gov/Biodefense/PDF/tarvacin.pdf

    Anti-Phospholipid Therapy / Bavituximab Anti-Viral

    Duke University's Human Vaccine Institute and the Center for HIV/AIDS Vaccine Immunology (CHAVI) is currently investigating PS as a potential target for preventing and treating HIV infection.
     
  2. acer2000

    acer2000 Senior Member

    Messages:
    670
    Likes:
    461
  3. minimus

    minimus

    Messages:
    32
    Likes:
    5
    Although it looks promising, it is a bad sign (to me at least) that the stock market value of Peregrine has declined 91% since 1996.
     
  4. August59

    August59 Daughters High School Graduation

    Messages:
    1,607
    Likes:
    585
    Upstate SC, USA
    Not sure if that would be a good sign that they are ripe for a buy out or should that have taken place before they fell that far?
     

See more popular forum discussions.

Share This Page